Article Details

eXmoor and Virica receive funding to improve AAV gene therapy manufacturing

Retrieved on: 2024-10-17 18:40:23

Tags for this article:

Click the tags to see associated articles and topics

eXmoor and Virica receive funding to improve AAV gene therapy manufacturing. View article details on hiswai:

Excerpt

BRISTOL, England & OTTAWA, Ontario, October 17, 2024--eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up